Fitbit’s AFib app gets FDA clearance, will be available in October: 4 details

More posts on digital transformation:8 current health IT, innovation partnershipsHow 6 health systems are individualizing patient experience for infant boomers, millennials and Gen ZProvidence Digital Innovation Group program manager heads to Facebook

Fitbit got FDA 510( k) clearance for its electrocardiogram app to examine heart rhythm for atrial fibrillation.
4 details:
1. The Fitbit ECG app will be readily available in October on the Fitbit Sense gadget in the U.S. in addition to a number of other nations.
2. Fitbit conducted multisite clinical trials in the U.S. to assess its algorithm, designed to discover AFib from regular sinus rhythm and generate ECG trace. The research study showed the algorithm exceeded target performance and revealed the capability to detect 98.7 percent of AFib cases; it was also 100 percent precise recognizing normal sinus rhythm in study participants.
3. Users can also take check readings of their heart to evaluate for AFib by holding their fingers to a stainless-steel ring on the watch for 30 seconds; they can download their outcomes to show physicians.
4. Fitbit Sense costs $329.95 and can be bought online or in stores in late September.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.